2 employees
SpherIngenics is at the forefront of the biotechnology industry as it delivers the next generation of medicines: cell-based therapies.
2007
$730K
from 1 investors over 1 rounds
SpherIngenics raised $730K on June 13, 2012
Investors: united-states-department-of-defense